Surgery Partners, Inc.
SGRY
NASDAQ·Healthcare·Medical - Care Facilities·Mkt cap $1.9B
$14.26
▲ +0.64%
P/E
-20.67
Mkt Cap
$1.9B
52-Wk Range
$11.41–$23.44
52-Week Range
$11.41 - $23.44
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 35.4% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Integrated multi-specialty surgical platform with 126 facilities across 31 states providing scale and operational efficiency
- Vertical integration of surgical facilities with ancillary services creating synergies, improved patient outcomes, and higher margins
- Diversified surgical specialty portfolio reducing dependence on single procedure types and providing revenue stability
- Established relationships with physicians and payers built through years of operational experience and market presence
Bear Case
2 risks
- Above-average volatility (beta 1.9).
- Significant premium - growth priced in
Growth
Turning profitable
Steady revenue growth (6% YoY)
Value
Significant premium - growth priced in
Momentum
Stable
+2.9% over 3m
Quality
Stable
Strong fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying SGRY right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 9, 2026
AUG 10, 2026
Reported EPS of $0.10 vs $0.06 consensus (+72.6% surprise). Revenue of $848.9M vs $830.0M expected (+2.3%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+72.6%
Revenue trend · last 8Q
—
+18%
+8%
+8%
+7%
+2%
+4%
+3%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$770.4M
$864.4M
$776.0M
$826.2M
$821.5M
$885.0M
$810.9M
$848.9M
Margins · last 8Q
Gross
22.4%
Operating
12.0%
Profit
-1.8%
Wall Street consensus
2 analysts · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: Cantor Fitzgerald · Aug 11, 2026
vs Industry
How SGRY stacks vs Medical - Care Facilities
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related